Tim Coughlin

Former Chief Financial Officer at Neurocrine Biosciences Inc.

Tim Coughlin

Tim Coughlin

Former Chief Financial Officer at Neurocrine Biosciences Inc.


Timothy P. Coughlin is on the board of aTyr Pharma, Inc., Fate Therapeutics, Inc. and Retrophin, Inc. In the past he was Vice President at Neurocrine Biosciences, Inc., Senior Manager-Health Sciences Practice at Ernst & Young LLP and Vice President-Financial Services at California Healthcare Institute. Mr. Coughlin received an undergraduate degree from Temple University (Pennsylvania) and a graduate degree from San Diego State University.

Career Highlights

Neurocrine Biosciences Inc.

RelSci Relationships


Number of Boards






RelSci Relationships are individuals Tim Coughlin likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Fate Therapeutics, Inc.

Relationship likelihood: Strong

Founder at Fate Therapeutics, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Retrophin, Inc.

Relationship likelihood: Strong

Co-Founder at REPLIGEN Corp.

Relationship likelihood: Strong

Former President & Chief Executive Officer at Neurocrine Biosciences Inc.

Relationship likelihood: Strong

Advisor at IIF Management Co. LLC

Relationship likelihood: Strong

Partner at Polaris Partners

Relationship likelihood: Strong

President & Chief Executive Officer, Director at aTyr Pharma, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Atreca, Inc.

Relationship likelihood: Strong

Former Auditor at PricewaterhouseCoopers LLP

Relationship likelihood: Strong

Paths to Tim Coughlin
Potential Connections via
Relationship Science
Tim Coughlin
Former Chief Financial Officer at Neurocrine Biosciences Inc.
Masters in International Business

San Diego State University (SDSU, State) is a public research university in San Diego, and is the largest and oldest higher education facility in San Diego County. Founded in 1897 as San Diego Normal School, it is the third-oldest university in the 23-member California State University (CSU), and is considered the flagship campus of the entire system. SDSU has a student body of more than 34,000 and an alumni base of more than 260,000. The university awards 189 types of bachelor's degrees, 91 different master's degrees, 22 types of doctoral degrees including Ed.D, Ed.S, DPT, J.D., Au.D, Ph.D. programs in collaboration with Claremont Graduate University,UC Davis, UC Riverside, UCSD, and UCSB. The university also offers 26 different teaching credentials.SDSU offers more doctoral degrees than any other campus in the California State University system.

Bachelor's in Accounting

Temple University is a national center of excellence in teaching and research with an international presence. Our talented faculty and broad curriculum of over 400 academic programs provide superior educational opportunities for academically talented and highly motivated students, without regard to their status or station in life.

Career History
Chief Financial Officer
2002 - 2017

Neurocrine Biosciences, Inc. operates as a product based bio-pharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company product includes INGREZZA. Neurocrine Biosciences was founded by Kevin C. Gorman and Wylie W. Vale on January 1992 and is headquartered in San Diego, CA.

Senior Manager, Health Sciences Practice
1989 - 1999

Ernst & Young LLP engages in the provision of assurance, tax, transactions, and advisory services. It offers audit, business risk, technology, security risk, and human capital services. The company was founded by Arthur Young and Alwin C. Ernst in 1989 and is headquartered in New York, NY.

Vice President-Financial Services

CHI was founded in 1993 as an independent 501(c)(6) organization devoted to researching and advocating policy to forward the interests of California’s biomedical community.

Boards & Committees
Member, Board of Directors
2017 - Current

aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Independent Director
2015 - Current

Retrophin, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA.

Independent Director
2013 - Current

Fate Therapeutics, Inc. operates as a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorder. The firm programme cellular therapeutics for the treatment of life threatening diseases, hematologic malignancies, genetic disorders and diseases resulting from the dysregulation of the immune system. Its products include ProHema, ProTmune, Adaptive NK, iPSC-derived NK, Programmed CD34 and T cell therapy. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko and John D. Mendlein on April 27, 2007 and is headquartered in San Diego, CA.

Political Donations

Limited Partner at Lead Edge Capital Management LLC

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Tim Coughlin. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Tim Coughlin's profile does not indicate a business or promotional relationship of any kind between RelSci and Tim Coughlin.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/tim-coughlin-3204385
  • https://relationshipscience.com/person/tim-coughlin-3204385